Table 1.
Analysis of variance on the three selected groups
| Not admitted (n = 158; 11.0%) | Admitted without event (n = 986; 68.7%) | Admitted with event (n = 292; 20.3%) | P | |
|---|---|---|---|---|
| Age (years) | 51.6 ± 12.8 | 62.5 ± 15.3* | 71.3 ± 12#° | < 0.001 |
| Male gender | 82 (51.9%) | 617 (62.6%)* | 206 (70.6)#° | < 0.001 |
| Creatinine (mg/dl) | 0.80 [0.69–0.94] | 0.96 [0.78–1.16]* | 1.16 [0.87–1.62]#° | < 0.001 |
| Platelets (/mmc) | 233.99 ± 127.70 | 232.03 ± 96.86 | 210.23 ± 94.21#° | 0.003 |
| MR-proADM (nmol/L) | 0.57 [0.48–0.71] | 0.83 [0.63–1.16]* | 1.33 [0.97–2.03]#° | < 0.001 |
| WBC (/mmc) | 5.40 [4.35–6.50] | 6.44 [4.72–8.70]* | 7.53 [5.28–10.88]#° | < 0.001 |
| Lymphocytes (/mmc) | 1.20 [0.80–1.61] | 0.98 [0.70–1.33]* | 0.57 [0.81–1.14]#° | < 0.001 |
| LDH (U/L) | 471 [392–599] | 389 [276–555]* | 510 [375–735]#° | < 0.001 |
| PCT (mg/dl) | 0.05 [0.03–0.08] | 0.08 [0.04–0.14]* | 0.18 [0.09–0.46]#° | < 0.001 |
| CRP (mg/L) | 19.65 [9.42–46.12] | 60.07 [25–106.59]* | 103.12 [55.67–176]#° | < 0.001 |
| Cardiovascular disease | 8 (5.1%) | 216 (21.9%) * | 102 (34.9%)#° | < 0.001 |
| Chronic respiratory diseases | 9 (5.7%) | 148 (15.0%)* | 65 (22.3%)#° | < 0.001 |
| Diabetes | 17 (10.8%) | 175 (17.8%) | 111 (38%)#° | < 0.001 |
| Chronic kidney disease | 2 (1.3%) | 100 (10.1%)* | 83 (28.4%)#° | < 0.001 |
| Malignancy | 6 (3.8%) | 61 (6.2%) | 28 (9.6%) | 0.039 |
| Hypertension | 28 (17.7%) | 455 (46.2%)* | 184 (63%)#° | < 0.001 |
*: p < 0.05 post-hoc “not admitted” vs “admitted without event”; #: p < 0.05 post-hoc “not admitted” vs “admitted with event”; °: p < 0.05 post-hoc “admitted without event” vs “admitted with event”